Domov › Rak prostate › South Carolina › Myrtle Beach
Klinične študije za Rak prostate v Myrtle Beach, SC
24 študij za Rak prostate išče udeležence na lokacijah v Myrtle Beach in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
Vključevanje udeležencevFaza 3
- Carolina Urologic Research Center, Myrtle Beach
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- MUSC Hematology-Oncology at Murrells Inlet, Murrells Inlet · 13 mi stran
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
Vključevanje udeležencevOpazovalna študija
- Carolina Urologic Research Center, Myrtle Beach
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Vključevanje udeležencevFaza 1
- Carolina Urologic Research Center, Myrtle Beach
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Vključevanje udeležencevFaza 1/2
- Carolina Urologic Research Center, Myrtle Beach
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Vključevanje udeležencevFaza 1/2
- Research Site, Myrtle Beach
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Vključevanje udeležencevFaza 3
- Grand Strand Medical Center, Myrtle Beach
- Carolina Urologic Research Center, LLC, Myrtle Beach
- Parkway Surgery Center, Myrtle Beach
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
Vključevanje udeležencevFaza 1
- START Carolinas, Myrtle Beach
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Vključevanje udeležencevFaza 2/3
- Carolina Urologic Research Center, Myrtle Beach
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Vključevanje udeležencevFaza 3
- South Texas Accelerated Research Therapeutics - Carolinas, Myrtle Beach
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Vključevanje udeležencevFaza 3
- Carolina Urologic Research Center, Myrtle Beach
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Vključevanje udeležencevFaza 3
- Research Site, Myrtle Beach
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Vključevanje udeležencevFaza 2
- START Carolinas, Myrtle Beach
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Vključevanje udeležencevFaza 3
- Carolina Urologic Research Center, Myrtle Beach
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Vključevanje udeležencevFaza 2
- Carolina Urologic Research Center, Myrtle Beach
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Vključevanje udeležencevFaza 3
- Research Site, Myrtle Beach
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Vključevanje udeležencevFaza 2
- Carolina Urologic Research Center, Myrtle Beach
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Vključevanje udeležencevFaza 1
- Carolina Urologic Research Center, Myrtle Beach
PSMA PET Combined With MRI for the Detection of PCa
Vključevanje udeležencevFaza 3Vabljeni zdravi prostovoljci
- Atlantic Urology Specialists, Myrtle Beach
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Vključevanje udeležencevFaza 1
- Carolina Urologic Research Center, the START Center for Cancer Research, Myrtle Beach
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Vključevanje udeležencevFaza 1
- South Texas Accelerated Research Therapeutics - Carolinas, Myrtle Beach
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Vključevanje udeležencevFaza 1
- Carolina Urologic Research Center, Myrtle Beach
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Vključevanje udeležencevFaza 3
- Carolina Regional Cancer Center, Myrtle Beach
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
Vključevanje udeležencevFaza 2
- Carolina Urologic Research Center, Myrtle Beach
Študije za Rak prostate v drugih mestih
- New York City, NY103 študij
- Houston, TX76 študij
- Los Angeles, CA61 študij
- Boston, MA59 študij
- St. Louis, MO46 študij
- Chicago, IL45 študij
- San Francisco, CA45 študij
- Philadelphia, PA44 študij
- Baltimore, MD43 študij
- Nashville, TN43 študij
- Seattle, WA42 študij
- Washington, DC38 študij
Druge študije v Myrtle Beach
- Rak mehurja10 študij
- Nemuskularen invaziven rak mehurja9 študij
- Rak ledvic (renocelularni karcinom)6 študij
- Urotelialni (prehodnocelični) karcinom5 študij
- Metastatski rak5 študij
- Sladkorna bolezen tipa 23 študij
- Kastracijsko odporen rak prostate3 študij
- Rak (vse vrste)3 študij
- Karcinom in situ3 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.